Topic: Clinical Trial at Penn
A new clinical trial using gemcitabine, ironotecan and panitumumbab (a human monoclonal antibody against epidermal growth factor) has just started at the University of Pennsylvania. I am patient # 1 - and have very advanced AND metastatic disease (on imaging studies) and am on narcotics for pain though my liver function tests are holding up. I was in incredible health before this happened three months ago so maybe that has helped - plus I am determined to live long enough to get my children (15 & 17) through HS as I am already a widow . Anyway, although there is something else, I think, going on for me as I actually had some tumor shrinkage earlier than expected (after only one week of chemo) and have been megadosing with 50,000 IU Vit D a day, 1000 mg resveratol, and around 3 fish oils a day, I was told by a number of doctors I spoke to (including at Sloane Kettering and Pittsburgh) that this is a great trial (I am a doctor as well, BTW). Insurance will cover the first two drugs but not the panintumubab - which is being supplied by Amgen. Anyway - I will keep you all posted but I wanted to let you know about this. My physician is Nevena Damjanov (Nevena.Damjanov@uphs.upenn.edu) and I have been immensely pleased by her care. Anyway -- if you are interested I would contact her .............. Elizabeth
PS - I would also consider the supplements I am taking - see the website for the Vitamin D council. Even though there isn't data for CC some of the date for other cancers is encouraging ...... certainly led me to give it a try.